Hyun Il Cho

Title: Hyun Il Cho: Innovator in T Cell Immune Response Technologies

Introduction

Hyun Il Cho is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of immunology, particularly in developing technologies that enhance T cell immune responses. With a total of 5 patents, his work focuses on innovative approaches to combat diseases associated with the Epstein-Barr virus (EBV) and cancer.

Latest Patents

One of his latest patents is titled "HLA-A2 subtype-specific PLK1-derived epitope inducing antigen-specific T cell immune response to PLK1 protein." This invention relates to a specific epitope that can induce a CD8+ T cell immune response targeting tumor cells. Another notable patent is "EBV antigen specific T-cell receptor and use thereof." This invention provides T cells that are specifically designed to target the LMP1 antigen of EBV, which can be utilized in the prevention or treatment of EBV-associated diseases.

Career Highlights

Hyun Il Cho has worked with the Catholic University of Korea Industry-Academic Cooperation Foundation, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of T cell responses and their applications in medical treatments.

Collaborations

He has collaborated with notable colleagues such as Tai Gyu Kim and Moon Jun Bae, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Hyun Il Cho's innovative work in T cell immune response technologies showcases his dedication to advancing medical science. His patents reflect a commitment to developing solutions for critical health challenges, particularly in the fields of oncology and virology.